RT Journal Article SR Electronic T1 pS2 Gene Expression in HepG2 cells: Complex Regulation through Crosstalk between the Estrogen Receptor α, an Estrogen-Responsive Element, and the Activator Protein 1 Response Element JF Molecular Pharmacology JO Mol Pharmacol FD American Society for Pharmacology and Experimental Therapeutics SP 1273 OP 1283 DO 10.1124/mol.61.6.1273 VO 61 IS 6 A1 Barkhem, Tomas A1 Haldosén, Lars-Arne A1 Gustafsson, Jan-Åke A1 Nilsson, Stefan YR 2002 UL http://molpharm.aspetjournals.org/content/61/6/1273.abstract AB The pS2 promoter is complex with binding sites for a number of protein factors that may participate in modulating its activity. ThepS2 gene was transcriptionally activated by estrogens in HepG2 cells transformed (HepER3) to express the estrogen receptor α (ERα). The phorbol ester phorbol 12-myristate 13-acetate (PMA) stimulated pS2 expression in both HepER3 and the parental, non–ER-expressing HepG2 cells, although its activity was substantially less in HepG2 cells. The use of selective protein kinase inhibitors suggested that the MAPK pathway contributes substantially to estrogen stimulation of the pS2 promoter. The activator protein 1 (AP1) site at −332 to −338 in the pS2 promoter had a dominant role in the response to both estrogens and PMA, although the estrogen response element at −393 to −405 was essential to mediate the response to estrogen. The potentiation of pS2 promoter activity by the AP1 motif in response to estrogen was dependent on the ligand binding domain of ERα. Furthermore, the presence of an intact AP1 element in the pS2 promoter sustained suppression of pS2 promoter activity by an LXXLL peptide. In summary, the data suggest that the effect of estrogen is mediated through a cross-talk between the estrogen-responsive element and the AP1 response element and that ERα plays a crucial role in mediating the effect of both estrogen and PMA.